In one of the largest surveys of its kind, Omada polled more than 3,000 people who have used GLP‑1s for weight loss, offering a timely view of how the GLP‑1 experience is evolving and where the system continues to fall short. Read this article to learn about:
- Current barriers to GLP-1 care and health outcomes
- What patients wish their doctors and employers knew about the obesity care experience
- Shifts in cost and coverage and how they impact populations
- Four questions benefit leaders should be asking right now
Download Beyond Stigma and Scripts: What the System Gets Wrong About Obesity Care